
Perth Hospital First in Australia to Make Cancer Therapy
Royal Perth Hospital just became Australia's first facility licensed to manufacture breakthrough cancer therapies that train patients' own immune cells to fight tumors. Western Australian cancer patients will soon access cutting-edge treatments without leaving home.
Cancer patients in Western Australia are about to get something remarkable: access to breakthrough therapies manufactured right in their hometown, keeping them close to the people who matter most.
Royal Perth Hospital just received licenses from Australia's Therapeutic Goods Administration to manufacture two advanced cancer-fighting therapies. The hospital is now the first in the country authorized to produce tumor-infiltrating lymphocytes (TILs) and one of the few licensed for CAR T-cell therapy.
These aren't your typical cancer treatments. CAR T-cell therapy takes a patient's immune cells, re-engineers them in a lab to recognize cancer, and returns them to the body as targeted cancer killers. The therapy has shown promising results for certain blood cancers.
TIL therapy works differently but uses the same personalized approach. Doctors remove immune cells already fighting inside a patient's tumor, grow millions more in the lab, and infuse them back to overwhelm the cancer. Researchers are testing this approach for melanoma and other solid tumors.
Until now, Australian patients seeking these treatments faced a difficult choice: travel far from home for care or miss out entirely. Manufacturing these therapies locally changes that equation completely.

Medical Research Minister Stephen Dawson called the licenses "a proud moment for Western Australia." The approval recognizes years of work building expertise in cell and gene therapy at Royal Perth Hospital.
The first clinical trials using locally manufactured CAR T-cells and TILs are expected to begin before the end of 2026. Patients enrolled in these trials will help prove whether local manufacturing can deliver the same life-changing results seen elsewhere.
The Ripple Effect
Local manufacturing means more than convenience. Patients staying close to home can lean on their support networks during grueling treatment schedules. Families avoid the financial strain of relocating or frequent travel.
The facility also positions Western Australia as a leader in advanced medical manufacturing. Skills developed making these therapies could attract research talent and pharmaceutical investment to the region.
The WA government's Future Health Research and Innovation Fund and Clinical Trials Roadmap are backing the initiative. These programs aim to ensure Western Australians benefit from medical breakthroughs without waiting for them to trickle in from elsewhere.
Cancer treatment is getting smarter, and now it's getting closer to home too.
More Images

Based on reporting by Google News - Australia Breakthrough
This story was written by BrightWire based on verified news reports.
Spread the positivity!
Share this good news with someone who needs it


